Published in
Elsevier, EClinicalMedicine, (48), p. 101450, 2022
DOI: 10.1016/j.eclinm.2022.101450
Links
Tools
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19
Journal article published in 2022 by
Emanuele Nicastri,
Franco Marinangeli,
Emanuele Pivetta,
Elena Torri,
Francesco Reggiani,
Giuseppe Fiorentino,
Laura Scorzolini,
Serena Vettori,
Carolina Marsiglia 
,
Elizabeth Marie Gavioli ,
Andrea R. Beccari,
Giuseppe Terpolilli,
Maria De Pizzol,
Giovanni Goisis,
Flavio Mantelli
and other authors.
,
Elizabeth Marie Gavioli ,
Andrea R. Beccari,
Giuseppe Terpolilli,
Maria De Pizzol,
Giovanni Goisis,
Flavio Mantelli
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 